Sep 2026· Proceedings of the Thirty-Fifth International Joint Conference on Artificial Intelligence· pp. 340-347· 0 citations· 20 references
TL;DR
AgentRetro is a framework integrating spectral domain generalization with Large Language Model (LLM) agents that consistently improves state-of-the-art baselines, and reveals that explicitly decoupling structural invariance from mechanistic adaptability is essential for overcoming the interference between conflicting distribution shifts.
Abstract
Retrosynthesis prediction is a cornerstone of drug discovery, enabling the synthesis of novel therapeutic candidates. However, current deep learning models falter when navigating the unexplored chemical space essential for innovation. In these realistic scenarios, models face a challenging mixed out-of-distribution (OOD) shift: they must handle both novel molecular scaffolds (covariate shift) and unseen reaction templates (label shift), leading to severe performance degradation. To address this, we propose AgentRetro, a framework integrating spectral domain generalization with Large Language Model (LLM) agents. It features a Spectral Domain Enhancer (SDE) that partitions chemical space via spectral clustering to capture diverse domain structures, and a Multi-Knowledge Agent (MKA) that enriches data with LLM-generated OOD reactions and textual rationales. These components are unified by a dual training strategy: meta-learning for template adaptability and adversarial learning for structural invariance. Crucially, our analysis reveals that explicitly decoupling structural invariance from mechanistic adaptability is essential for overcoming the interference between conflicting distribution shifts. Experiments show AgentRetro consistently improves state-of-the-art baselines, notably boosting EditRetro’s OOD Top-10 accuracy from 41.7% to 50.1%. The source code is available at https://github.com/jiahangshen/IJCAI26-AgentRetro.
Drug repositioning has emerged as an attractive drug development strategy with deep learning-based computational methods showing great potential in predicting Drug-Disease Associations (DDAs). However, dominant computational paradigms typically rely on Random Negative Sampling (RNS) and static embedding fusion, leading...
Ke-Rui Xu, Ke-Yuan Xu, Shu-Hui Yin et al.· Proceedings of the Thirty-Fi...· 0 citations
CRAFT is a reaction-aware molecular optimization framework that integrates Monte Carlo Tree Search (MCTS) with a multimodal strategy network and explicitly encodes two-dimensional molecular topology and atom-level reaction roles, enabling chemically feasible transformations during multi-step optimization.
Run-Fu Yu, Tong-Mao Ma, Zian Song et al.· Journal of Medicinal Chemist...· 0 citations
Accurate identification of protein−nucleic acid binding sites is essential for elucidating molecular mechanisms and for enabling structure-based drug discovery. Existing computational approaches struggle to jointly model sequence, structure, and domain knowledge, which limits both predictive accuracy and interpretabi...
Wen-Yu Xi, Ru-Heng Wang, Xiu-Cai Ye et al.· ACS Synthetic Biology· 0 citations
Drug-target affinity prediction provides a computational basis for virtual screening and drug repositioning optimization by estimating the binding strength between compounds and target proteins. Existing deep learning methods have evolved from early SMILES/amino acid sequence modeling to graph neural networks and multi...
Yu-Ning Liu, Guang-Ze Wang, Dan Liu et al.· European journal of medicina...· 0 citations
Halogenated chalcones are emerging as an exciting class of potential anticancer scaffolds with respect to medicinal chemistry; they exhibit structural flexibility, multitarget pharmacology, and allow for rapid medicinal chemistry optimization. The biological activity associated with halogen substitutions on the scaffol...
Tamara Bassam Kamal Hijjawi· Natural Resources for Human...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.